Article
In silico design of novel recombinant antigens containing immunologically relevant regions of wild-type and escape mutant variants of HBsAg.
PloS one - 1 Jan 2026
Workneh Yeshwas Abite, Sisay Desye Melese, Fekadu Abebaw, Bika Abraham Tesfaye, Mogus Alemu Tekewe, Sisay Tessema Tesfaye
Abstract excerpt
Hepatitis B virus (HBV) contributes substantially to liver cancer, related mortality, and liver transplantation worldwide. The small hepatitis B surface antigen (HBsAg), particularly its major hydrophilic region (MHR) and the "a" determinant, is the primary target of serological diagnostics. However, escape mutant amino acid variants (EMAVs) within this region may reduce diagnostic specificity and sensitivity. In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
